Skip to main content

History

2017
22.11.2017.

Start of operation of the updated EudraVigilance system

Start of operation of the updated EudraVigilance system – an information system established and maintained by the European Medicines Agency (EMA) for collection of adverse drug reaction reports regarding medicines authorised and used in clinical research in all EEA countries.

21.11.2017. - 24.11.2017.

Campaign to promote reporting of adverse drug reactions

For the second time the Agency implements a social media campaign simultaneously with other EEA countries to promote reporting of adverse drug reactions. In 2017, campaign activities are mostly aimed at reporting adverse drug reactions caused by non prescription medicines.

03.11.2017.

Improved online search form of the Medicinal Product Register of Latvia

  1) Additional parameter “Disease group (by ATC)” allows searching for medicines intended for a specific disease group; 2) Added functionality that allows ordering selected list of medicines according to maximum price allowed in pharmacies.

18.09.2017. - 20.09.2017.

BEMA IV visit at the Agency

28.07.2017.

Design and publication of an online report form on Agency’s website allowing representatives of healthcare institutions to submit electronic vigilance reports related to human blood, tissues, cells and organs.

05.06.2017. - 09.06.2017.

European Medicines Agency and U.S. Food and Drug Administration conducted a joint audit

As part of the Joint audit program (JAP) of the European Union member states, European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) conducted a joint audit (inspection) of the compliance of processes organized and practical activities performed by the Agency with the international requirements in the field of compliance evaluation of good manufacturing practice and good distribution practice.

03.04.2017.

“How not to overpay for medicines?”

In March and April 2017, Agency implemented a public information campaign “How not to overpay for medicines?” in collaboration with the society Health Projects for Latvia. As part of the campaign, an informative bulletin “RATIONAL CHOICE OF MEDICINES” was prepared for doctors .

01.03.2017. - 30.04.2017.

Agency implemented a public information campaign “How not to overpay for medicines?” in collaboration with the society Health Projects for Latvia. An informative bulletin “RATIONAL CHOICE OF MEDICINES” was prepared for doctors.

14.02.2017.

Simplified electronic submission of adverse drug reaction report forms for all users of medicines: on Agency’s website – without authentication via the Latvija.lv portal.